Xenon CEO reports Form 4P transaction
Xenon Pharmaceuticals said President & CEO Mortimer Ianp filed Form 4P covering 30,000 shares at $37.38, or $1,121,400.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.